| abstract |
The present disclosure provides isolated Interferon alpha nucleic acids and polypeptides. The disclosure also provides antibodies which specifically recognize the subject Interferon alpha polypeptides, expression vectors containing the subject nucleic acids, and host cells expressing the subject polypeptides. In addition, methods of treatment using Interferon alpha are provided. |